Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pleiotropy01:33

Pleiotropy

44.0K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
44.0K
piRNA - Piwi-interacting RNAs02:57

piRNA - Piwi-interacting RNAs

7.8K
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
7.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of cancer antigen 15-3 with distant recurrence in immunohistochemically defined breast cancer subtypes in Canadian Cancer Trials Group MA.32.

JNCI cancer spectrum·2026
Same author

Exploration of BMI and circulating metabolic factors as predictors of metformin benefit in CCTG MA.32.

JNCI cancer spectrum·2026
Same author

Pan-cancer N-glycoproteomic atlas of patient-derived xenografts uncovers FAT2 as an actionable surface target.

Cell reports. Medicine·2026
Same author

β-catenin turnover is regulated by Nek10-mediated tyrosine phosphorylation in A549 lung adenocarcinoma cells.

Proceedings of the National Academy of Sciences of the United States of America·2024
Same author

Insulin receptor loss impairs mammary tumorigenesis in mice.

Cell reports·2023
Same author

Effect of Metformin Versus Placebo on New Primary Cancers in Canadian Cancer Trials Group MA.32: A Secondary Analysis of a Phase III Randomized Double-Blind Trial in Early Breast Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023

Related Experiment Video

Updated: Mar 23, 2026

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
09:30

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Published on: August 17, 2022

3.6K

PTEN at 18: Still Growing.

Olena Gorbenko1, Vuk Stambolic2

  • 1Princess Margaret Cancer Centre, University Health Network, Room 13-313, Toronto Medical Discovery Tower, 101 College Street, Toronto, M5G 1L7, ON, Canada.

Methods in Molecular Biology (Clifton, N.J.)
|April 2, 2016
PubMed
Summary
This summary is machine-generated.

PTEN, a key tumor suppressor, is extensively studied for its role in cancer. New methods are crucial for understanding its complex functions and regulation in PTEN loss-driven tumors.

Keywords:
DNA damage repairGenome integrityPI3K signalingPTENPhosphataseTumor suppressor

More Related Videos

Assessment of Open Probability of the Mitochondrial Permeability Transition Pore in the Setting of Coenzyme Q Excess
07:35

Assessment of Open Probability of the Mitochondrial Permeability Transition Pore in the Setting of Coenzyme Q Excess

Published on: June 1, 2022

2.7K
Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase
10:33

Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase

Published on: October 15, 2018

8.7K

Related Experiment Videos

Last Updated: Mar 23, 2026

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
09:30

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Published on: August 17, 2022

3.6K
Assessment of Open Probability of the Mitochondrial Permeability Transition Pore in the Setting of Coenzyme Q Excess
07:35

Assessment of Open Probability of the Mitochondrial Permeability Transition Pore in the Setting of Coenzyme Q Excess

Published on: June 1, 2022

2.7K
Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase
10:33

Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase

Published on: October 15, 2018

8.7K

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • PTEN (Phosphatase and Tensin homolog) is a critical tumor suppressor discovered in 1997.
  • Its broad expression, subcellular localization, and phosphatase activity are central to its function.
  • Mutations and loss of PTEN are implicated in various cancers.

Purpose of the Study:

  • To present a collection of clinical and experimental methodologies for studying PTEN.
  • To address the challenges in characterizing PTEN due to its complex regulation and modifications.
  • To facilitate a deeper understanding of PTEN's role in cancer biology.

Main Methods:

  • Review of diverse experimental approaches for PTEN research.
  • Development of PTEN knockout/knock-in models (animals and cell lines).
  • Utilization of specific antibodies and enzymatic assays for PTEN characterization.

Main Results:

  • Methodologies have been developed to overcome challenges in studying PTEN's dynamic nature.
  • Advancements in PTEN research tools enable controlled characterization.
  • A significant body of work has been facilitated by these ongoing efforts.

Conclusions:

  • Studying PTEN requires sophisticated experimental systems due to its complex biology.
  • Continued development of research tools is essential for unraveling PTEN's functions.
  • Understanding PTEN is vital for advancing cancer research and therapy.